61.   Biotech stocks, however, did well.

62.   Meanwhile, there was interest in biotech stocks as scientific magazines published for the first time the complete human genome map and sequence.

63.   The news sent biotech stocks tumbling and dragged the rest of the Nasdaq composite index down with it.

64.   Witness, for example, the current popularity of biotech stocks and mutual funds.